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Abstract:  Sonophoresis temporarily increases skin permeability such that medicine can be delivered transdermally. 
Cavitation is believed to be the predominant mechanism in sonophoresis. In this study, an ultrasound contrast agent 
(UCA) strategy was adopted instead of low frequency ultrasound to assure that cavitation occurred, and the efficacy of 
sonophoresis with UCA was quantitatively analyzed by optical measurements. The target drug used in this study was 0.1 
% Definity® in 70% glycerol, which was delivered into porcine skin samples. Glycerol was used because it is an optical 
clearing agent, and the efficiency of glycerol delivery could be analyzed with optical measurements. The applied acoustic 
pressure was approximately 600 kPa at 1 MHz ultrasound with a 10% duty cycle for 60 minutes. Experimental results 
indicated that the measured relative contrast (RC) after sonophoresis with UCA was approximately 80% higher than RC 
after sonophoresis without UCA. In addition, the variance of RC was also reduced by more than 50% with the addition of 
a UCA. The use of a UCA appeared to increase cavitation, demonstrating that the use of a UCA can be effective in 
transdermal drug delivery (TDD).  
Keywords: Transdermal drug delivery, ultrasound contrast agent, cavitation, sonophoresis, non-invasive drug delivery, optical 
clearing agent. 
INTRODUCTION 
  Transdermal drug delivery (TDD) has great advantages 
compared to oral drug delivery in that it avoids 
gastrointestinal degradation and bypasses first-pass drug 
metabolism by the liver [1, 2]. However, TDD has been 
limited in the past due to low skin permeability since the 
stratum corneum (SC), the outermost layer of the skin, 
presents a formidable barrier. Hence, the steady delivery of 
large amounts of medicine is difficult to achieve with TDD. 
  Numerous innovative technologies have been developed 
to temporarily increase skin permeability in order to increase 
the applicability of TDD. Iontophoresis, which utilizes 
electric current to drive charged molecules through the skin, 
has been studied for the last 30 years [3-5]. As a result, 
numerous iontophoretic TDD systems are currently 
available. Although iontophoresis is quite effective as a TDD 
method, the great disadvantage is that drugs must be ionized 
before use. Electroporation uses very short (e.g., msec) high 
voltage (e.g., 100 – 1000V) pulses to increase skin 
permeability [1, 6-8]. However, its application can be limited 
due to pain caused by the electrical pulses [9]. Sonophoresis 
generally uses relatively low frequency ultrasound (e.g., 
<100 kHz) compared to ultrasound imaging systems [2], 
[10], which causes the cavitation of bubbles trapped on the 
skin. Although cavitation can be a violent event, 
sonophoresis has not been shown to cause significant skin 
damage [11, 12] Sonophoresis has also been shown to 
 
 
*Address correspondence to this author at the Department of Biomedical 
Engineering, Yonsei University, S. Korea; Tel: +82-(0)33-760-2961; Fax: 
+82-(0)33-765-5483; E-mail: jongbums@yonsei.ac.kr 
effectively deliver various types of drugs regardless of their 
electrical characteristics and can easily be coupled with other 
TDD methods to enhance the drug delivery rate. 
  Cavitation is a stochastic event due to random bubble 
size, but its application has been investigated in many 
biomedical areas. Actively-induced cavitation was used to 
lower the energy threshold of tissue damage in ultrasound 
surgery in the presence of an ultrasound contrast agent 
(UCA) in the form of engineered microbubbles [13]. UCAs 
have also been used to temporarily reduce the blood brain 
barrier (BBB) with low intensity ultrasound [14, 15]. 
Additionally, UCAs have also been investigated for their use 
as carriers for targeted drug delivery [16-18]. 
  In the work presented here, sonophoretic TDD was 
studied in the presence of UCA. The commercially available 
UCA Definity® was used to enhance the optical clearing 
agent glycerol for delivery into porcine skin. The efficacy of 
sonophoresis with UCA was quantitatively and 
comparatively analyzed. The presented method was expected 
to be one of the most efficient, non-invasive TDD methods 
to date. 
BACKGROUND 
  Microbubbles located near a boundary can be excited 
using an acoustic field to create asymmetric flows [19, 20] 
While stable cavitation occurs, microstreaming can be 
induced due to non-symmetric boundary conditions around 
the microbubbles. Additionally, shear stress can also be 
induced along the boundary. When combined, these two 
factors can temporarily increase skin permeability. On the 
other hand, asymmetric bubble collapse can be induced if the Transdermal Drug Delivery Aided by an Ultrasound Contrast Agent  The Open Biomedical Engineering Journal, 2010, Volume 4    57 
applied acoustic field has a large enough amplitude to cause 
inertia cavitation [19]. This bubble collapse can cause jet 
streaming into the boundary such that materials can be 
actively transported from outside to inside the boundary. 
  To assure cavitation, the use of low frequency acoustic 
fields has been adopted [2, 10, 11] because if the 
insonification frequency is low enough compared to the 
bubble resonance frequency, the given acoustic field can be 
assumed to be a quasi-static field, and inertia cavitation can 
be induced. However, this method may not efficient due to 
the fact that the existing bubbles are random in size. 
  A more efficient way to ensure cavitation could be to 
adopt a method where UCA with ultrasound was used at its 
resonance frequency. UCAs are engineered microsized 
bubbles such that they can be stably sustained within the 
fluid. Albumin, lipid, and polymers have all been used as 
shell materials to provide a balance force against Laplace 
pressure due to the curvature of the bubbles [16, 21, 22]. 
Safe and inert perfluorocarbon gases are generally used to 
generate the microbubbles. Since the size of the 
microbubbles is one of the dominant factors in determining 
the response characteristics to ultrasound stimulation, UCAs 
are usually filtered at the final stage of production; therefore 
UCAs have a resonance frequency in the MHz range and the 
distribution and the size of the microbubbles can be 
controlled by the addition of UCA. 
METHOD 
Skin Preparation 
  Porcine skin samples were used for these experiments as 
they are easy to access and their anatomical characteristics 
are similar to those of human skin [23]. Porcine skin samples 
were obtained and preserved by refrigeration at 5 ºC for no 
longer than five days. The subcutaneous fat layer was 
removed before experimentation, and the thickness of tissue 
samples ranged from 2.0 - 2.1 mm with an average thickness 
of 2.06 mm. Before the experiment, the prepared sample was 
kept in room temperature for approximately half an hour, so 
that the initial temperature was around 20-24°C. 
Target Drug & UCA 
  The optical clearing agent glycerol was used as the target 
drug since the efficiency of sonophoresis in the presence of 
UCA can be visualized and quantitatively analyzed. If 
glycerol is transported into the skin, dehydration and 
collagen dissociation causes the index of refraction to better 
match that of air and the skin becomes more transparent [24, 
25]. Therefore, the efficiency of TDD can be quantitatively 
analyzed with optical measurements. For this experiment, 
70% glycerol was used. 
  The UCA Definity® (Bristol-Myers Squibb Medical 
Imaging, Inc., USA) was used to assure cavitation at high 
frequency in the MHz range because Definity® has a lipid-
based shell and it can be mixed well with glycerol. 
Definity® was activated by Vialmix® (Lantheus Medical 
Imaging, Inc., USA) for 45 seconds and then 1 l Definity® 
was added into 1 ml glycerol. The mixture was blended 
again with Vialmix® for uniform distribution of Definity®.  
Experiment 
  To visualize and analyze the TDD effect, a polarization 
variable imaging system (MAG Vision OptoBioMed, Korea) 
was used as shown in Fig. (1). The system consists of a 
linearly polarized LED ring light source and rotatable linear 
polarization analyzer. A CCD camera (MAG2000®, Canon, 
Japan) was located above the prepared skin sample for image 
acquisition. Images were taken every 20 minutes for 60 
minutes using the cross-polarization mode of the imaging 
system in a dark room to prevent illuminant variation. 
  TDD efficacy was quantitatively evaluated by calculating 
the contrast and relative contrast (RC) of the modulation 















Fig. (1). Experimental Setup. Approximately 1 ml of 70% Glycerol was used as optical clearing agents. If ultrasound used with or without 
UCA, 1 MHz ultrasound transducer for 20 minutes span. In case UCA was applied to the experiment, 0.1 % concentration was chosen to use 
according to the guideline in UCA specification. After optical image was taken identical procedure was conducted twice more. Inner ring 
light sources were used to provide uniform luminance to the porcine skin sample. 
CCD camera
RLP
FLP Inner ring light sources
• RLP : Rotatible Linearly Polarizer
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black and white strips on in order to modulation function on 
image. A region of interest (ROC) was defined as the central 
region of glycerol application corresponding to a 1.5 x 1.5 
cm
2 area extracted from each image. Contrast and RC were 
calculated as a function of time after glycerol application as 










                 (2) 
where MC0 and MCt are the mean contrasts of MTFT in the 
ROC before glycerol application and after the elapsed time 
(t), respectively. 
  Six different experimental sets were conducted for 
comparison as shown in Table 1 and individual set was 
conducted five times. To provide base control data, 
experiment I was designed where 70% glycerol was topically 
applied and no other active TDD method was adopted. In 
experiment II, 0.1% Definity® was added to the 70% 
glycerol solution, and the mixture was applied topically 
without ultrasound insonification, which was conducted to 
determine if UCA alone could introduce chemically-induced 
active TDD. 
  Sonophoresis without UCA was conducted in experiment 
III. A generic, pain reducing ultrasound system (DM77, 
Daeyang Inc., Korea) was used in all ultrasound 
insonification experiments. A single-element, 1 MHz 
transducer with an approximately 4.7 cm diameter aperture 
was used in the experiments. After glycerol application, the 
transducer was kept in good contact with the glycerol but 
was not allowed to press against the skin sample directly, 
leaving an approximate 2 mm distance between the 
transducer and the skin sample. Ten msec long pulses were 
used every 100 msec (10% duty cycle) for a total of 60 
minutes. To ensure skin surface temperature was kept under 
40ºC for practical use, the peak pressure was set to 
approximately 600 kPa. This value was obtained based upon 
back calculation of the total acoustic power measurement in 
water using equation (1) under the assumption that the 
acoustic pressure was evenly generated from the surface of 
the transducer; 
 p = 2pcI                  (3) 
where  is water density, C is the speed of sound in water, 
and I is measured intensity. 
In experiment IV, a microneedle roller (Dermaroller, Horst 
Liebl, France) was used to create microchannels prior to 
sonophoresis. The needle size used was 70 m in diameter 
and 500 m in height. The roller had 192 needles on the 
cylindrical surface at a density of 240 channels/cm
2. The 
roller was applied to the skin samples 50 times each in the 
horizontal, vertical, and diagonal directions. Although 
microneedling creates artificial transport channels 
invasively, the trapped air in the indented pockets also act as 
microbubbles. Glycerol was topically applied after 
microneedling, and the ultrasound was insonified as in 
experiment III. 
  UCA was used in conjunction with sonophoresis in 
experiment V with the same 0.1% Definity®/70% glycerol 
mixture as described in the previous section. The ultrasound 
parameters were identical to those in experiment III. 
Experiment VI was identical to experiment V except that the 
microneedling procedure occurred prior to sonophoresis with 
UCA.  
RESULTS 
 Fig.  (2) shows examples of the experimental results. 
MTFT could be seen more clearly when more glycerol was 
delivered into the skin, as shown in Fig. (2). Since the initial 
condition of skin samples varied, the absolute contrast may 
not be a relevant way to compare the results. Nevertheless, 
sonophoresis in the presence of UCA still appeared to be the 
most effective method compared to the other TDD methods 
(Fig. 2).  
  Contrast plots and relative contrast plots in Figs. (3 and 
4) show the analytic comparison of individual results. As can 
be seen in Fig. (3), contrast was improved most by 
sonophoresis with UCA without advanced microneedling, 
although the standard deviation overlaps slightly. The 
relative contrast plot in Fig. (4) indicates that glycerol was 
delivered most efficiently by sonophoresis with UCA. Based 
on the experimental setup shown in Fig. (1), it should be 
noted that light travels through the skin sample twice before 
image recording, indicating that MTF of the skin will be 
squared in the current experiment, and an even linear 
increase will be shown as a second-order polynomial 
increase. As expected, the data in Figs. (3 and 4) more 
closely resemble a second-order polynomial than they do a 
line.  
Table 1.  Experimental Conditions 
Experiment No.  Experiment Condition  Purpose 
Ex 1  glycerol only  Control 
Ex 2  glycerol + UCA  Possible chemical cause 
Ex 3  glycerol + ultrasound (US)  Sonophoresis effect 
Ex 4  glycerol + microneedling (MN) + US  Air pocket + channel 
Ex 5  glycerol + UCA + US  Cavitation control cavitation 














Fig. (2). Representative contrast images. Contrast images indicate that glycerol can be effectively delivered with sonophoresis with UCA. 



















Fig. (3). Absolute Contrasts. Sonophoresis with UCA shows most improvement in absolute contrast.  
  Average RC, the square root of the average RC, and 
standard deviations (STD) of RC were summarized in Tables 
2 and 3. As demonstrated by the data in Fig. (4), 
microneedling did not seem to have a positive effect on 
sonophoresis, even though micro-sized channels were 
formed in advance. This may have occurred if the created 
channels acted as air pockets instead of as transporting 
channels in sonophoresis. Since the needle size was 70 m in 
diameter and 500 m in height, the created pocket size was 
expected to be on the order of 10 m in diameter, at the 
least. Hence, the resonance frequency will be much lower 
than the 1 MHz insonification frequency. 
  Another interesting observation of Fig. (4) and Table 4 
was that the variance was small if ultrasound was applied in 
the presence of UCA without microneedling. This result may 
indicate that cavitation may be more controllable by 
regulating the bubbles, as in UCA. 
  During the 10% duty cycle insonification, the 
temperature at the tissue surface increased by approximately 
10ºC from 24ºC to 33ºC (see Fig. 5). Although the increase 
in temperature would be reduced in practical applications 
due to blood circulation, the effect of temperature in the 
current results should be isolated with cavitation. Therefore, 
a 1% duty cycle insonification was conducted and the results 
were compared to experiment V. The 1% duty cycle 
Ex 1. Glycerol
Ex 5. Glycerol + UCA + US
Ex 6. Glycerol + MN + UCA 
+ US
Ex 3. Glycerol + US
Ex 4. Glycerol + MN + US
Ex 2. Glycerol + UCA
0 min 20 min 40 min 60 min


















Ex 2. Glycerol + UCA
Ex 4. Glycerol + MN + US
Ex 3. Glycerol + US
Ex 6. Glycerol + UCA + MN + US

















Fig. (4). Relative Contrasts. Sonophoresis with UCA increases the relative contrast approximately 40 times. Additionally, RC is 80% higher 
compared to sonophoresis without UCA.  
 
Table 2.  Average Relative Contrasts (Standard Deviation) 
  After 0 min  After 20 min  After 40 min  After 60 min 
Ex  1  1  1.29(0.34) 2.26(1.01) 8.51(4.19) 
Ex  2  1  1.63(0.58) 4.36(2.50) 7.78(3.16) 
Ex 3  1  3.30(4.24)  12.09(4.01)  24.20(8.05) 
Ex 4  1  3.81(1.97)  10.94(4.22)  22.13(7.45) 
Ex 5  1  3.87(1.68)  18.30(5.59)  40.66(3.93) 
Ex 6  1  4.12(2.58)  16.87(4.72)  31.05(5.14) 
 
Table 3.  Square Root of Average Relative Contrast (RC) 
  After 0 min  After 20 min  After 40 min  After 60 min 
Ex  1  1  1.14 1.50 2.92 
Ex  2  1  1.28 2.50 2.79 
Ex  3  1  1.81 3.48 4.92 
Ex  4  1  1.95 3.31 4.70 
Ex  5  1  1.97 4.28 6.38 
Ex  6  1  2.03 4.11 5.57 
 
insonification still delivered glycerol effectively, although 
the used energy was only 10% of that in experiment V and 
the temperature increase was nominal (Table 4). Therefore, 
cavitation was the predominant mechanism over a thermal 
mechanism, and UCA could provide an affirmative 
environment for sonophoresis. 
DISCUSSION 
  Since skin is not perfectly smooth, air pockets will 
always be formed on the skin surface. However, the size and 
the distribution of air pockets cannot be controlled. 
Traditionally, sonophoresis has been adopted low frequency 
to insure the caviation under this circumstance [2, 3, 10]. If 
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Fig. (5). Temperature profile during ultrasound insonification. 
 
Table 4.  RC of Duty Cycle 10% and 1% Insonification (Square Root of RC) 
  After 0 min  After 20 min  After 40 min  After 60 min 
10%(Ex 5)  1  3.87(1.97)  18.30(4.28)  40.66(6.38) 
1% 1  2.95(1.72)  13.86(3.72)  30.35(5.50) 
 
the applied frequency is low enough compared to resonance 
frequency of the formed bubble, then it can be modeled as 
quasi pressure. In quasi-static low pressure, bubble can grow 
up to breaking stage. However, the efficiency will be low. 
This problem may be overcome by introducing UCA since 
UCA has specific size distribution fit to MHz range 
resonance frequency. Preliminary experimental results seem 
to support this hypothesis.  
  Although cavitation is a matter of probability, the results 
indicate that cavitation seems to be controllable and useful in 
TDD. To maximize cavitation in the presence of UCA, 
ultrasound parameters such as frequency, intensity, duty 
cycle, pulse repetition rate and pulse duration need to be 
optimized. In addition, the viscosity of the fluid and the type 
of UCA used need to be considered for individual drugs to 
be delivered. The viscosity of the fluid can be a deterministic 
factor for resonance frequency, and the surface materials of 
individual UCAs have different hydrophilic characteristics, 
which can be a determining factor in mixing drugs with 
UCA.  
  Although the efficacy of sonophoresis in the presence of 
UCA was shown using an in vitro system, in vivo animal 
model experiments need to be conducted for deterministic 
verification. In addition, drugs that are clinically relevant 
need to be studied with the suggested TDD method. Future 
work will include parameter optimization and the use of 
various animal models investigating insulin delivery by 
sonophoresis with UCA. Additionally, low frequency can be 
still used in the presence of UCA even though the resonance 
frequency does not match. Hence, low frequency driving 
system and equipment are being prepared for the further 
study. 
CONCLUSIONS 
  The efficacy of sonophoresis with 0.1% UCA was 
quantitatively analyzed using optical measurements. 
Glycerol was used as the target drug for the purpose of 
optical clearance. Experimental results indicated that the 
proposed TDD method improved RC by approximately 80% 
compared to traditional sonophoresis at 1 MHz. In addition, 
the variance of RC was reduced by more than 50%. Based on 
these results, cavitation, which is believed to be the main 
mechanism in TDD, seems to be more predictable due to the 
small amount of UCA used. The proposed TDD method is 
expected to be useful for the transdermal delivery of various 
drugs. 
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